Das, Satya http://orcid.org/0000-0002-7625-1039
Dasari, Arvind
Article History
Accepted: 18 January 2021
First Online: 14 March 2021
Compliance with Ethical Standards
:
: Satya Das has received research funding from Exelixis and Entrinsic Health, and received compensation from Ipsen for previously serving on a speaker's bureau. Arvind Dasari has received research funding from Novartis / Advanced Accelerator Applications (AAA), Hutchison MediPharma, and Eisai, and has served on advisory boards for Ipsen, Novartis / AAA, Lexicon, and Crinetics.
: This article does not contain any studies with human or animal subjects performed by the authors.